Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Roundhill Magnificent Seven ETF (MAGS) Price & Performance

ADMA Biologics IncTrade
Roundhill Magnificent Seven ETFTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Roundhill Magnificent Seven ETF — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Roundhill Magnificent Seven ETF trades at $68.5. The key difference: Roundhill Magnificent Seven ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAMAGS
Market Cap
$2.22B
Sector
HealthSector/Thematic
52-Week High
$20.38$70.94
52-Week Low
$7.60$55.39
Enterprise Value
$2.29B

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Roundhill Magnificent Seven ETF

MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.

Read more on MAGS